• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Self-identified lesbians associated with decreased HPV vaccination

byJeffrey CampbellandSai Folmsbee
May 11, 2015
in Infectious Disease, Obstetrics, Public Health
Reading Time: 3 mins read
Reduced HPV vaccine doses may be adequate
Share on FacebookShare on TwitterShare on LinkedIn

1. From a cross-sectional study of women aged 15-25 years, women who self-identified as lesbians and had heard of the HPV vaccine were less likely to have initiated vaccination than heterosexuals.

2. Women who did not report their sexual orientation, predominantly Latina immigrants of lower socioeconomic status, were significantly less likely to have heard of the vaccine than self-identified heterosexuals.

Evidence Rating Level: 2 (Good)

Study Rundown: All women are at risk of acquiring human papilloma virus (HPV), a virus that can cause cervical and other cancers. However, prior research has indicated that cervical cancer screening is less common among lesbian women than their heterosexual counterparts. This study investigated whether young American women’s sexual orientation was associated with either awareness of the HPV vaccine or initiation of vaccination. Among this study population, sexual orientation was not associated with awareness of the HPV vaccine. However, compared to heterosexual women, awareness was significantly lower among women who did not report sexual orientation; these women were predominantly Latina immigrants with low socioeconomic status. Although most were aware of the HPV vaccine, significantly fewer women who identified as lesbians had started the series of three vaccinations compared to their heterosexual counterparts. Notably, this study was limited by the use of self-reports of HPV vaccine awareness and initiation, and only included a small number of women who identified as lesbians. Furthermore, the study was unable to assess whether women who started the vaccine process completed the full series of HPV vaccines. Nevertheless, these results suggest that lesbian women may be less likely to initiate HPV vaccination, even if they are aware of the vaccine, indicating that they may be a key population to whom future education could be targeted.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Reproductive Health Screeining Disparities and Sexual Orientation in a Cohort Study of US Adolescent and Young Adult Females.

RELATED REPORTS

Poor rates of surveillance follow-up noted in patients with high risk human papillomavirus and normal cytology

The Scan by 2 Minute Medicine®: Stroke in Young Patients with Lupus, At-home Cervical Screening, Vaccinated and Acne Free! A Future Possibility, The Rise of a New Synthetic Opioid

In-Depth [cross-sectional study]: Currently, the Advisory Committee on Immunization Practices recommends HPV vaccination for all women and girls between 11-26 years of age. This study included data on self-reported sexual orientation, awareness of the HPV vaccine, and initiation of vaccination among US women and girls aged 15-25, using the 2006-2010 National Survey of Family Growth, a national probability sample of US women. Of 3253 women included, 84.4% had ever heard of the HPV vaccination and 28.5% had initiated vaccination. After adjusting for covariates, among women who had heard of the vaccine, lesbians were significantly less likely to have initiated vaccination than their heterosexual counterparts (8.5% vs. 28.4%, p = 0.007). In addition, women who did not report sexual orientation were significantly less likely to have heard about the HPV vaccine than their heterosexual counterparts (68.4% vs. 84.4%, p=0.004). There were no significant differences in either awareness or initiation of vaccination between women who identified as heterosexual and bisexual. Further research is needed to identify potential drivers of these disparities in HPV awareness and vaccination prevalence.

 

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hpvhpv vaccine
Previous Post

Higher mortality among frequent ED users compared to non-frequent users

Next Post

Prednisolone vs placebo in severe alcoholic hepatitis [Classics Series]

RelatedReports

Quick Take: T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
Chronic Disease

Poor rates of surveillance follow-up noted in patients with high risk human papillomavirus and normal cytology

January 25, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Stroke in Young Patients with Lupus, At-home Cervical Screening, Vaccinated and Acne Free! A Future Possibility, The Rise of a New Synthetic Opioid

February 6, 2024
#VisualAbstract: Ross procedure associated with long-term survival outcomes into third postoperative decade
StudyGraphics

#VisualAbstract: Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer

December 6, 2023
Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
Next Post
Classics Series, Landmark Trials in Medicine

Prednisolone vs placebo in severe alcoholic hepatitis [Classics Series]

Mediterranean diet may reduce age-related neurocognitive decline

Mediterranean diet may reduce age-related neurocognitive decline

Clinical decision rule highly sensitive in predicting subarachnoid hemorrhage

2 Minute Medicine Rewind May 3 – May 10, 2015

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.